These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18470911)

  • 1. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
    Hedley BD; Welch DR; Allan AL; Al-Katib W; Dales DW; Postenka CO; Casey G; Macdonald IC; Chambers AF
    Int J Cancer; 2008 Aug; 123(3):526-34. PubMed ID: 18470911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
    Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
    Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
    Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
    Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
    Zhang S; Lin QD; DI W
    Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
    Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
    Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression.
    Wu Y; Jiang W; Wang Y; Wu J; Saiyin H; Qiao X; Mei X; Guo B; Fang X; Zhang L; Lou H; Wu C; Qiao S
    PLoS One; 2012; 7(8):e42976. PubMed ID: 22927944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
    Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR
    J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
    Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
    Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
    Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
    Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.
    Cicek M; Samant RS; Kinter M; Welch DR; Casey G
    Clin Exp Metastasis; 2004; 21(2):149-57. PubMed ID: 15168732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
    Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
    Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
    Suzuki M; Mose E; Galloy C; Tarin D
    Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis.
    Lombardi G; Di Cristofano C; Capodanno A; Iorio MC; Aretini P; Isola P; Tancredi M; Collecchi P; Naccarato AG; Porta RP; Bevilacqua G; Caligo MA
    Int J Cancer; 2007 Mar; 120(6):1169-78. PubMed ID: 17163420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mechanisms underlying BRMS1 suppression of metastasis.
    Samant RS; Seraj MJ; Saunders MM; Sakamaki TS; Shevde LA; Harms JF; Leonard TO; Goldberg SF; Budgeon L; Meehan WJ; Winter CR; Christensen ND; Verderame MF; Donahue HJ; Welch DR
    Clin Exp Metastasis; 2000; 18(8):683-93. PubMed ID: 11827072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.